TwistDx

The portable device runs an isothermal amplification assay to detect genetic material from strains of tuberculosis in resource limited areas.  

Companies in the life science tools and molecular diagnostics spaces provided updates on their businesses at the 36th annual JP Morgan Healthcare Conference this week in San Francisco.

Dubbed "Sherlock," the new technology has demonstrated potential in detecting viruses and bacteria as well as human SNPs and mutations in cell-free DNA.

The adaptable technology uses flow-through microfluidic chips and can detect three pathogens simultaneously with virtually unlimited potential array sizes. 

The system uses off-the-shelf laboratory components and currently runs an Ebola assay based on isothermal amplification chemistry from Alere subsidiary TwistDx.

Trends included expanding test menus and a possible tipping point for point-of-care.

Researchers tested three methods - a bandage, an elastic sweatband, and a strip of cotton fabric - for securing tubes (whose position is noted with arrows) in the axilla.

Isothermal molecular method incubated in the armpit allows researchers to detect HIV-1 DNA in proof-of-concept study.

NEW YORK (GenomeWeb) — Although Alere launched the Alere i molecular diagnostic platform and influenza assay only three months ago, the company announced this week that a three-year contract worth up to $12.9 million from the US Department of Health and Human Services' Biomedical Advanced Researc

NEW YORK (GenomeWeb) — This week, Waltham, Mass.-headquartered medical diagnostics company Alere received FDA clearance for a new influenza test that can both detect and discriminate nucleic acids of influenza A and influenza B viruses.

NEW YORK (GenomeWeb) — Researchers at The Royal Tropical Institute in Amsterdam have developed a novel isothermal recombinase polymerase amplification assay for pathogenic Leptospira, the spirochete bacterium that causes leptospirosis.

Pages

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.